Abbott (ABT) Launches FDA-Approved CRC Blood Test

Abbott launched SimpleScreen CRC, an FDA-approved blood-based colorectal cancer screening test for average-risk adults 45+, developed by Freenome and commercialized by Abbott. The test showed 81.1% CRC sensitivity and 90.4% specificity; it is covered by Medicare.Material DetailsContext by AI Analys…